# Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

> **NCT00124917** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 6 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00124917
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07-21
- **Primary completion:** 2011-03-06
- **Final completion:** 2017-05-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study closed due to unanticipated toxicity/risks to subjects.
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124917, "Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00124917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*